Methylphenidate
- Generic Name
- Methylphenidate
- Brand Names
- Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 113-45-1
- Unique Ingredient Identifier
- 207ZZ9QZ49
- Background
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve ...
- Indication
Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
Large-scale Brain Organization During Cognitive Control in ADHD
- Conditions
- Interventions
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 37
- Registration Number
- NCT04349917
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
The Effects of a Single Dose of Methylphenidate on Motor Performance
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- Loewenstein Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04283604
- Locations
- 🇮🇱
Sharon Tsuk, Netanya, Israel
The Role of Methylphenidate on Performance in the Cold
- Conditions
- Interventions
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2021-02-09
- Lead Sponsor
- Brock University
- Target Recruit Count
- 24
- Registration Number
- NCT04283877
- Locations
- 🇨🇦
Environmental Ergonomic Laboratory - Brock University, St. Catharines, Ontario, Canada
Differences by Sex and Genotype in the Effects of Stress on Executive Functions
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 146
- Registration Number
- NCT04273880
- Locations
- 🇨🇦
Developmental Cognitive Neuroscience Lab, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- IRCCS Eugenio Medea
- Target Recruit Count
- 20
- Registration Number
- NCT04272021
- Locations
- 🇮🇹
IRCCS Eugenio Medea, Bosisio Parini, Italy
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
- Conditions
- Interventions
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Craig Rush
- Target Recruit Count
- 8
- Registration Number
- NCT04178993
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States
Real World Evidence of the Efficacy and Safety of FOQUEST
- Conditions
- Interventions
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Purdue Pharma, Canada
- Target Recruit Count
- 257
- Registration Number
- NCT04152629
- Locations
- 🇨🇦
Health Sciences North, Sudbury, Ontario, Canada
🇨🇦Matheson Centre for Mental Health Research & Education, University of Calgary, Calgary, Alberta, Canada
🇨🇦Alpha recherche clinique, Québec, Quebec, Canada
A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
- First Posted Date
- 2019-10-21
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 430000
- Registration Number
- NCT04132557
- Locations
- 🇺🇸
Janssen Investigative Site, Titusville, New Jersey, United States
The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study
- Conditions
- Interventions
- First Posted Date
- 2019-05-03
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 105
- Registration Number
- NCT03936491
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
- Conditions
- Interventions
- First Posted Date
- 2019-01-24
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT03814356
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.